Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis

QR Code

Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis

Javier Zarranz-Ventura, 1, 2 Joshua O Mali 3 1Clinical Institute of Ophthalmology (ICOF), Hospital Clinic, Barcelona, Spain; 2August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; 3The Eye Associates, Sarasota, FL, USACorrespondence: Javier Zarranz-VenturaClinical Institut...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Zarranz-Ventura J, Mali JO
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2020
Sujets:	area under the curve best-corrected visual acuity diabetic macular edema corticosteroid fluocinolone acetonide implant dexamethasone implant Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/f9c4b7e1d20b4d15a1a3dc919e148a3a
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]
par: Zarranz-Ventura J, et autres
Publié: (2020)

Letter to the Editor Regarding the “Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The Constant Analysis” Article [Letter]
par: Taylor K, et autres
Publié: (2020)

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
par: Coelho J, et autres
Publié: (2019)

Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
par: Massin P, et autres
Publié: (2016)

Ahmed glaucoma valve in uveitic patients with fluocinolone acetonide implant-induced glaucoma: 3-year follow-up
par: Kubaisi B, et autres
Publié: (2018)

Real-World Outcomes in Diabetic Macular Edema for the 0.2 μg/Day Fluocinolone Acetonide Implant: Case Series from the Midlands, UK
par: Mushtaq B, et autres
Publié: (2021)

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations
par: Adán A, et autres
Publié: (2020)

Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE
par: Elbarky AM
Publié: (2020)

Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment
par: Steeples LR, et autres
Publié: (2021)

Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literature
par: Saedon H, et autres
Publié: (2017)

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes
par: Udaondo P, et autres
Publié: (2021)

Update on corticosteroids for diabetic macular edema
par: Schwartz SG, et autres
Publié: (2016)

Central Pars Plana Vitrectomy + Phacoemulsification + Intraocular Lens Implantation in Patients with Small Eyes, Cataract, and Narrow Anterior Chambers
par: Silva Cayatopa F, et autres
Publié: (2021)

Usefulness of anti-vascular endothelial growth factor combined with dexamethasone implant for retinal vein occlusion
par: Kim M
Publié: (2016)

A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome
par: Vadalà M, et autres
Publié: (2020)

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone
par: Zola M, et autres
Publié: (2017)

Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective
par: Urbančič M, et autres
Publié: (2019)

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
par: Wallsh J, et autres
Publié: (2016)

Macular edema resolution assessment with implantable dexamethasone in diabetic retinopathy (MERIT): a pilot study
par: Chhablani J, et autres
Publié: (2018)

Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region
par: Wei W, et autres
Publié: (2021)

Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy
par: Cham A, et autres
Publié: (2016)

Effects of Repeated Intravitreal Injections of Dexamethasone Implants on Intraocular Pressure: A 4-Year Study
par: Pacella E, et autres
Publié: (2020)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea
par: Kim MS, et autres
Publié: (2021)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
par: Laine I, et autres
Publié: (2017)

25G lens resection combined with anterior vitrectomy in the treatment of congenital cataract
par: Fu-Rong Liao, et autres
Publié: (2021)

Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema
par: Karttunen T, et autres
Publié: (2019)

Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
par: Wallsh J, et autres
Publié: (2020)

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
par: Tufail A, et autres
Publié: (2018)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
par: Thomas BJ, et autres
Publié: (2016)

Dexamethasone release from photopolymerised PEGDA700 for cochlea drug delivery
par: Thomas Eickner, et autres
Publié: (2020)

Anti-inflammatory drug-eluting implant model system to prevent wear particle-induced periprosthetic osteolysis
par: Rivera MC, et autres
Publié: (2019)

Dismal Survival in COVID-19 Patients Requiring ECMO as Rescue Therapy after Corticosteroid Failure
par: Sebastian Voicu, et autres
Publié: (2021)

Is There a Difference in the Resonance Frequency Values Obtained Directly on the Implants and Abutments?
par: Pozzer,Leandro, et autres
Publié: (2015)

Outcomes of Epiretinal Membrane Removal Utilizing Triamcinolone Acetonide Visualization and Internal Limiting Membrane Forceps
par: Asahi MG, et autres
Publié: (2020)

Transdermal permeability of triamcinolone acetonide lipid nanoparticles
par: Qin ZM, et autres
Publié: (2019)

Long-Term Outcomes of Macular Hole Repair with Triamcinolone Acetonide Visualization
par: Wallsh J, et autres
Publié: (2021)

Actualización en Implantes Subperiósticos: Ranc-Implants Presentación de un Caso Clínico y Revisión de la Literatura
par: Rancaño-Álvarez,Emilio Adolfo, et autres
Publié: (2019)

Clinical implant dentistry and related research
Publié: (1999)

Clinical oral implants research
Publié: (1990)

Managing solar retinopathy with suprachoroidal triamcinolone acetonide injection in a young girl: a case report
par: Ameen Marashi, et autres
Publié: (2021)